|
Eli Lilly shares popped early Tuesday after the drugmaker reported first-quarter profit that topped estimates amid strong demand for diabetes and weight-loss drugs.
|
|
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion Yahoo FinanceEli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro CNBCEli Lilly's GLP-1 demand drives up stock price post-Q1 results Yahoo FinanceLilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum | Eli Lilly and Company Investors | Eli Lilly and CompanyLilly Touts 26% Q1 Revenue Growth on Strong Mounjaro Sales, Raises Full-Year Guidance by $2B BioSpace
|
|